The 2-year ROC curves for both TCGA and ICGC showed high values in all the patient groups, highlighting VNN3 as a good prognostic biomarker for the relatively early stages of ccRCC (Figure 3(B,D)). Here, VNN3P is linked to nonpapillary renal cell carcinoma.